New COVID-19 Variant Emerges

Omicron Subvariant EG5 Circulating in Canada

Rapidly Rising and Easily Transmissible

A new COVID-19 Omicron subvariant, EG5, has been circulating in Canada since at least May, according to the Public Health Agency of Canada. This subvariant is rapidly rising and is now the dominant strain in multiple countries, including the United States. While it may cause a range of symptoms, studies suggest that EG5's symptoms generally last no longer than those of other SARS-CoV-2 variants or subvariants.

The emergence of EG5 serves as a reminder that the coronavirus continues to mutate and evolve. As this new subvariant gains momentum, it is crucial to remain vigilant and continue practicing public health measures, such as vaccination, masking, and social distancing.

Symptoms of COVID-19, including EG5, can vary widely and may include:

• Change in sense of taste or smell
• Fever
• Cough
• Difficulty breathing
• Fatigue
• Body aches

If you are experiencing any symptoms of COVID-19, it is important to get tested and isolate to prevent further spread of the virus. Stay informed about the latest public health guidance and recommendations to protect yourself and your loved ones from this evolving pandemic.